CNS specific antisense oligonucleotides are short, synthetic strands of nucleic acids designed to selectively bind to RNA targets within the central nervous system. By modulating gene expression, these therapies can reduce or alter the production of disease-causing proteins. Their ability to precisely target genetic mutations makes them highly promising for neurodegenerative and rare genetic...